Placenta percreta is a condition where chorionic villi penetrate the entire myometrium, extending beyond uterine serosa. Here, we present an interesting case of placenta percreta in a 32-year-old lady with a previous history of the lower segment cesarean section. Initial ultrasonography had revealed oligohydramnios and an anterior low lying placenta with myometrial invasion, suggestive of placenta increta. Subsequently, a pre-operative magnetic resonance imaging demonstrated further invasion of the uterine serosa and bladder dome involvement which confirmed placenta percreta.
Background: Iron deficiency is a major cause for anaemia. IDA is associated with significant maternal, fetal and infant morbidity. Iron deficiency is potentially both preventable and treatable. Current treatment options are limited and include oral iron supplementation, which can be ineffective and poorly tolerated and red blood transfusions which carry an inherent risk and should be avoided. Ferric caboxymaltose is a new treatment option that is better tolerated and has rapid improvement in hemoglobin levels. This study was designed to assess safety and efficacy of ferric caboxymaltose in pregnant anaemic patients. Methods: It was a prospective observational study included 50 anaemic pregnant patients who received ferric carboxymaltose in second and third trimester of pregnancy. Effectiveness was assessed by repeat haemoglobin estimation after 4 weeks. Safety was assessed by analysis of adverse reactions and foetal heart rate monitoring during infusion. Results: Most of the women were in age group 20-25 yrs and had mild anaemia as per WHO guidelines. Intravenous ferric carboxymaltose significantly improved hemoglobin levels in all women which was statistically significant p value (0.00). No serious adverse events were noted. Conclusion: Intravenous ferric carboxymaltose is a safe and effective treatment option for anaemia in pregnant patientsn.
Background: Gestational diabetes is defined as glucose intolerance with its first onset or first recognition during pregnancy. Gestational diabetes patients are at an increased risk for both maternal and poor fetal outcome. Aim: This study was done to determine adverse maternal and perinatl outcome in women diagnosed with gestational diabetes. Materials and Methods: It is a retrospective study of women who were attending antenatal OPD and delivered in our institution and were diagnosed with gestational diabetes. Case records of previous two years of delivered women with gestational diabetes were studied from January 2016 to December 2017.Their demographic chracterstics, associated maternal comorbidities, adverse maternal and perinatal outcome were noted. Results: A total of 40 of gestational diabetes in our institution were studied between this 2 year period. 60% of patients belong to the age group 25-30 years. 20% belong to the rural and 80% belong to urban population. GDM patients had a higher rate of associated comorbidities like PIH, Hypothyroidism, high incidence of UTI and candidiasis, higher rate of cesarean delivery, higher admissions to NICU. 42.5% of patients had their blood glucose level controlled on di et al. one while rest required oral hypoglycemic and/or insulin. Majority of second gravida patients had GDM in their first pregnancy also. Conclusion: Since the prevalence and diagnosis of GDM is on an increase and is associated with adverse maternal as well as adverse fetal outcome, early diagnosis and a good control of blood sugar levels should be done in order to achieve optimal maternal and perinatal outcome.
Introduction: In order to have healthy mother and baby, adequate antenatal care is a must. Poor antenatal care is an important risk factor for adverse pregnancy outcomes among women 1 So this study was done to assess the knowledge and practices of antenatal women in rural central India and also that despite having adequate knowledge about antenatal care what prevents them from having that desired level of care. Material and methods: This was a cross sectional study done in January 2019 on 100 antenatal women with full term pregnancy in Vidisha district. Data was collected using predesigned proforma. After the data was collected using predesigned questionnaire, subjects were also counseled regarding the importance of regular antenatal care and about breastfeeding and contraception. Results: Majorty of women were in 20-30 yrs age group (95%). 70% were Hindu, 42% were primigravida 58% were multigravid only 88% remembered there LMP. Only 10% confirmed their pregnancy by upt, 50% had their 1 st visit to hospital in 1 st trimester 40% in 2 nd trimester & 10% in third trimester 80% women had their 1 st usg in 2 nd trimester 100% received tt vaccination, 90% received iron & calcium supplements but only 60% continued to take them till term when asked about the danger signs in pregnancy, pain as a danger sign was said by 80% of women, bleeding pv was said by 66% of women, leaking pv was said by 56% women whereas fever was said by only 10%, loss/ decreased fetal movements was said by only 10% of women, also excessive vomiting was as a danger sign was said by 10% women only knowledge about post partum contraception was poor 100% of women knew about early initiation of breastfeeding and 80% were willing to continue till one year. 83% of mothers said that breastfeeding should be started within 24 h. when asked about the reasons for their inadequate follow-up during pregnancy, lack of adequate knowledge (70%), lack of company to visit the hospital (30%), inaccessibility (8%), were major causes. 33% women said they did not have any complains so they did not have routine antenatal care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.